#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15604	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2038	759.7	0	.	n	.	0	C451T	SNP	451	451	C	684	684	T	894	T,C	675,175	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15604	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2038	759.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1417	1417	C	914	C	849	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28516	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	788.6	0	.	n	.	0	T695C	SNP	695	695	T	1035	1035	C	845	C,A	792,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28516	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	788.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	959	C	885	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28516	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	788.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	923	A	870	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28516	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	788.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	898	C	859	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28516	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3607	788.6	0	HET	.	.	.	C539T	.	539	539	C	879	879	C	971	C,T	664,230	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2084	folP	855	855	100.0	folP.l15.c30.ctg.1	1538	135.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1017	1019	AGC	203;201;203	A;G;C	195;194;195	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	162.7	1	SNP	p	S91F	1	.	.	271	273	TTC	528	530	TTC	165;168;168	T;T;C	158;161;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	162.7	1	SNP	p	G95N	0	.	.	283	285	GGC	540	542	GGC	170;170;170	G;G;C	161;164;164	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3345	162.7	1	SNP	p	D95G	1	.	.	283	285	GGC	540	542	GGC	170;170;170	G;G;C	161;164;164	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1732	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1223	140.5	1	SNP	p	G45D	0	.	.	133	135	GGC	436	438	GGC	227;228;229	G;G;C	214;213;215	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	780	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1003	77.6	0	.	n	.	0	A197.	DEL	197	197	A	584	584	A	176	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5212	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2943	176.6	1	SNP	p	D86N	0	.	.	256	258	GAC	582	584	GAC	219;219;217	G;A;C	195;190;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5212	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2943	176.6	1	SNP	p	S87R	1	.	.	259	261	CGT	585	587	CGT	219;219;219	C;G;T	195;193;193	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5212	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2943	176.6	1	SNP	p	R87I	0	.	.	259	261	CGT	585	587	CGT	219;219;219	C;G;T	195;193;193	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5212	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2943	176.6	1	SNP	p	R87W	0	.	.	259	261	CGT	585	587	CGT	219;219;219	C;G;T	195;193;193	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5212	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2943	176.6	1	SNP	p	S88P	0	.	.	262	264	TCC	588	590	TCC	216;218;222	T;C;C	192;196;196	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4400	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2688	163.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1657	1659	GGC	205;203;204	G;G;C	196;193;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1233	1235	GCC	237;239;240	G;C;C	224;226;230	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1236	1238	ATG	242;239;238	A;T,C;G	229;227,1;227	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1248	1250	ACC	234;236;236	A;C;C	219;220;222	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1248	1250	ACC	234;236;236	A;C;C	219;220;222	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1749	1751	ACC	235;231;232	A;C;C	214;215;218	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1803	1805	GCG	232;231;229	G;C;G	214;215;210	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1803	1805	GCG	232;231;229	G;C;G	214;215;210	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1926	1928	GGT	183;181;180	G;G;T	167;166;162	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1935	1937	AGC	175;175;172	A;G;C	154;156;151	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4258	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2332	181.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1953	1955	CCG	148;150;151	C,G,T;C,G;G	117,4,1;120,1;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5854	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3163	184.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1663	1665	CCG	225;228;224	C;C,A;G	201;208,1;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2144	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1807	117.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	576	576	C	140	C	133	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	889	891	AGA	257;257;255	A;G;A	245;243;243	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	910	912	GGT	240;237;239	G;G;T	227;228;229	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1015	1017	GAA	250;251;253	G;A;A	231;235;236	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	1	SNP	p	G120K	1	.	.	358	360	AAG	619	621	AAG	254;250;247	A;A;G,A	237;236;230,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	1	SNP	p	A121N	1	.	.	361	363	AAC	622	624	AAC	247;250;255	A;A;C	233;236;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3096	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1543	199.6	1	SNP	p	N121D	0	.	.	361	363	AAC	622	624	AAC	247;250;255	A;A;C	233;236;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11780	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4844	242.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1033	134.0	1	SNP	p	V57M	1	.	.	169	171	ATG	470	472	ATG	288;290;294	A;T;G,T	272;274;272,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
